Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B

D. L. Calhoun, G. D. Roberts, J. N. Galgiani, J. E. Bennett, D. S. Feingold, J. Jorgensen, G. S. Kobayashi, S. Shadomy

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

In a survey of 350 laboratories, 41 of 210 respondents indicated that they performed antifungal susceptibility tests. Two-thirds performed 20 or fewer tests per year, and most used a broth dilution method to test amphotericin B and flucytosine activity against Candida albicans. The broth dilution procedure of S. Shadomy and A. Espinel-Ingroff (p. 647-653, in E.H. Lennette, ed., Manual of Clinical Microbiology, 3rd ed., 1980) was the method most frequently cited, and therefore this method was used to test the susceptibility of five isolates of C. albicans and one of Saccharomyces cerevisiae to amphotericin B and flucytosine in seven research laboratories. Agreement among replicates performed on the same day by each laboratory was excellent for both drugs, all values being within 1 twofold drug dilution. Precision from week to week for each laboratory was also good, with 95% and 92% of values being within 1 drug dilution for amphotericin B and flucytosine, respectively. Interlaboratory precision, however, was poor. For amphotericin B, values varied 8- to 32-fold, and for flucytosine, they varied 32- to >512-fold. We conclude that antifungal susceptibility testing is currently being performed in small volumes by numerous laboratories in the United States and that results from one laboratory may not agree with results from another. Improved standardization of fungal susceptibility tests is necessary before their results can be generally applied to clinical situations.

Original languageEnglish (US)
Pages (from-to)298-301
Number of pages4
JournalJournal of Clinical Microbiology
Volume23
Issue number2
StatePublished - 1986
Externally publishedYes

Fingerprint

Flucytosine
Amphotericin B
Candida albicans
Pharmaceutical Preparations
Microbiology
Saccharomyces cerevisiae
Surveys and Questionnaires
Research

ASJC Scopus subject areas

  • Microbiology (medical)
  • Microbiology

Cite this

Calhoun, D. L., Roberts, G. D., Galgiani, J. N., Bennett, J. E., Feingold, D. S., Jorgensen, J., ... Shadomy, S. (1986). Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B. Journal of Clinical Microbiology, 23(2), 298-301.

Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B. / Calhoun, D. L.; Roberts, G. D.; Galgiani, J. N.; Bennett, J. E.; Feingold, D. S.; Jorgensen, J.; Kobayashi, G. S.; Shadomy, S.

In: Journal of Clinical Microbiology, Vol. 23, No. 2, 1986, p. 298-301.

Research output: Contribution to journalArticle

Calhoun, DL, Roberts, GD, Galgiani, JN, Bennett, JE, Feingold, DS, Jorgensen, J, Kobayashi, GS & Shadomy, S 1986, 'Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B', Journal of Clinical Microbiology, vol. 23, no. 2, pp. 298-301.
Calhoun, D. L. ; Roberts, G. D. ; Galgiani, J. N. ; Bennett, J. E. ; Feingold, D. S. ; Jorgensen, J. ; Kobayashi, G. S. ; Shadomy, S. / Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B. In: Journal of Clinical Microbiology. 1986 ; Vol. 23, No. 2. pp. 298-301.
@article{7bc8b80bcc3d4296a0b64836093e07ba,
title = "Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B",
abstract = "In a survey of 350 laboratories, 41 of 210 respondents indicated that they performed antifungal susceptibility tests. Two-thirds performed 20 or fewer tests per year, and most used a broth dilution method to test amphotericin B and flucytosine activity against Candida albicans. The broth dilution procedure of S. Shadomy and A. Espinel-Ingroff (p. 647-653, in E.H. Lennette, ed., Manual of Clinical Microbiology, 3rd ed., 1980) was the method most frequently cited, and therefore this method was used to test the susceptibility of five isolates of C. albicans and one of Saccharomyces cerevisiae to amphotericin B and flucytosine in seven research laboratories. Agreement among replicates performed on the same day by each laboratory was excellent for both drugs, all values being within 1 twofold drug dilution. Precision from week to week for each laboratory was also good, with 95{\%} and 92{\%} of values being within 1 drug dilution for amphotericin B and flucytosine, respectively. Interlaboratory precision, however, was poor. For amphotericin B, values varied 8- to 32-fold, and for flucytosine, they varied 32- to >512-fold. We conclude that antifungal susceptibility testing is currently being performed in small volumes by numerous laboratories in the United States and that results from one laboratory may not agree with results from another. Improved standardization of fungal susceptibility tests is necessary before their results can be generally applied to clinical situations.",
author = "Calhoun, {D. L.} and Roberts, {G. D.} and Galgiani, {J. N.} and Bennett, {J. E.} and Feingold, {D. S.} and J. Jorgensen and Kobayashi, {G. S.} and S. Shadomy",
year = "1986",
language = "English (US)",
volume = "23",
pages = "298--301",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "2",

}

TY - JOUR

T1 - Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B

AU - Calhoun, D. L.

AU - Roberts, G. D.

AU - Galgiani, J. N.

AU - Bennett, J. E.

AU - Feingold, D. S.

AU - Jorgensen, J.

AU - Kobayashi, G. S.

AU - Shadomy, S.

PY - 1986

Y1 - 1986

N2 - In a survey of 350 laboratories, 41 of 210 respondents indicated that they performed antifungal susceptibility tests. Two-thirds performed 20 or fewer tests per year, and most used a broth dilution method to test amphotericin B and flucytosine activity against Candida albicans. The broth dilution procedure of S. Shadomy and A. Espinel-Ingroff (p. 647-653, in E.H. Lennette, ed., Manual of Clinical Microbiology, 3rd ed., 1980) was the method most frequently cited, and therefore this method was used to test the susceptibility of five isolates of C. albicans and one of Saccharomyces cerevisiae to amphotericin B and flucytosine in seven research laboratories. Agreement among replicates performed on the same day by each laboratory was excellent for both drugs, all values being within 1 twofold drug dilution. Precision from week to week for each laboratory was also good, with 95% and 92% of values being within 1 drug dilution for amphotericin B and flucytosine, respectively. Interlaboratory precision, however, was poor. For amphotericin B, values varied 8- to 32-fold, and for flucytosine, they varied 32- to >512-fold. We conclude that antifungal susceptibility testing is currently being performed in small volumes by numerous laboratories in the United States and that results from one laboratory may not agree with results from another. Improved standardization of fungal susceptibility tests is necessary before their results can be generally applied to clinical situations.

AB - In a survey of 350 laboratories, 41 of 210 respondents indicated that they performed antifungal susceptibility tests. Two-thirds performed 20 or fewer tests per year, and most used a broth dilution method to test amphotericin B and flucytosine activity against Candida albicans. The broth dilution procedure of S. Shadomy and A. Espinel-Ingroff (p. 647-653, in E.H. Lennette, ed., Manual of Clinical Microbiology, 3rd ed., 1980) was the method most frequently cited, and therefore this method was used to test the susceptibility of five isolates of C. albicans and one of Saccharomyces cerevisiae to amphotericin B and flucytosine in seven research laboratories. Agreement among replicates performed on the same day by each laboratory was excellent for both drugs, all values being within 1 twofold drug dilution. Precision from week to week for each laboratory was also good, with 95% and 92% of values being within 1 drug dilution for amphotericin B and flucytosine, respectively. Interlaboratory precision, however, was poor. For amphotericin B, values varied 8- to 32-fold, and for flucytosine, they varied 32- to >512-fold. We conclude that antifungal susceptibility testing is currently being performed in small volumes by numerous laboratories in the United States and that results from one laboratory may not agree with results from another. Improved standardization of fungal susceptibility tests is necessary before their results can be generally applied to clinical situations.

UR - http://www.scopus.com/inward/record.url?scp=0022637374&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022637374&partnerID=8YFLogxK

M3 - Article

C2 - 3517051

AN - SCOPUS:0022637374

VL - 23

SP - 298

EP - 301

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 2

ER -